Events & Presentations
Upcoming Events
There are currently no events to display.
Archived Events
| Date | Event Details |
|---|---|
| Summary Toggle Aug 29, 2019 8:00 AM EDT |
Study 1002-058 Phase 2 Top-Line Results |
| Summary Toggle Jun 26, 2019 4:30 PM EDT |
Oberland Capital / Esperion – Revenue-based Funding Agreement
View Presentation 262.5 KB
|
| Summary Toggle Jun 13, 2019 9:00 AM EDT |
Esperion Analyst and Investor Day |
| Summary Toggle May 20, 2019 9:30 AM EDT |
UBS Global Healthcare Conference |
| Summary Toggle May 14, 2019 6:55 PM EDT |
Bank of America Merrill Lynch Healthcare Conference 2019 |
| Summary Toggle Jan 9, 2019 5:30 PM PST |
2019 JP Morgan Healthcare Conference Presentation |
| Summary Toggle Jan 4, 2019 8:00 AM EST |
Daiichi Sankyo Europe / Esperion – EU Commercialization Agreement |
| Summary Toggle Nov 15, 2018 5:00 AM EST |
Jefferies London Healthcare Conference |
| Summary Toggle Nov 13, 2018 11:10 AM EST |
Credit Suisse 27th Annual Healthcare Conference |
| Summary Toggle Oct 29, 2018 8:00 AM EDT |
Phase 3 Top-Line Results from Study 2 & Cumulative Phase 3 Program Results
View Presentation 1.8 MB
Supplemental Information 946.8 KB
|
| Summary Toggle Aug 27, 2018 8:00 AM EDT |
Top-Line Results from the Bempedoic Acid / Ezetimibe Combination Pill Phase 3 Study |
| Summary Toggle Jul 10, 2018 9:00 AM EDT |
Esperion Analyst and Investor Day |
| Summary Toggle Jun 20, 2018 10:00 AM EDT |
The JMP Securities Life Science Conference |
| Summary Toggle Jun 5, 2018 2:30 PM EDT |
Jefferies 2018 Global Healthcare Conference -Fireside Chat |
| Summary Toggle May 23, 2018 10:30 AM EDT |
UBS Global Healthcare Conference |
| Summary Toggle May 23, 2018 8:45 AM EDT |
Phase 3 Top-Line Results from Study 3 |
| Summary Toggle May 15, 2018 3:00 PM PDT |
Bank of America Merrill Lynch 2018 Healthcare Conference
View Presentation 862.4 KB
|
| Summary Toggle May 8, 2018 3:30 PM EDT |
43rd Annual Deutsche Bank Health Care Conference
View Presentation 833.2 KB
|
| Summary Toggle May 2, 2018 8:30 AM EDT |
Phase 3 Top-Line Results from Study 1
View Presentation 2.1 MB
Supplemental Materials 2.7 MB
|
| Summary Toggle Mar 27, 2018 8:30 AM EDT |
Phase 2 Top-Line Results from Study 039 |
| Summary Toggle Mar 12, 2018 4:50 PM EDT |
The 38th Annual Cowen Healthcare Conference |
| Summary Toggle Mar 7, 2018 8:30 AM EST |
Phase 3 Top-line Results from Study 4 |
| Summary Toggle Jan 10, 2018 2:00 PM EST |
36th Annual J.P. Morgan Healthcare Conference |
| Summary Toggle Oct 17, 2017 8:30 AM EDT |
Analyst and Investor Day Event |
| Summary Toggle Aug 8, 2017 8:30 AM EDT |
Q2 2017 Earnings Conference Call & Combo + Statin Top-Line Results
View Presentation 384.9 KB
|
| Summary Toggle Jun 26, 2017 4:30 PM EDT |
Bempedoic Acid / Ezetimibe Combination Regulatory Pathway Update |
| Summary Toggle Apr 17, 2017 8:00 AM EDT |
2017 Annual Meeting of Stockholders
Meeting Presentation 391.1 KB
|
| Summary Toggle Mar 20, 2017 8:00 AM EDT |
Bempedoic Acid Regulatory Strategy Update |
| Summary Toggle Mar 19, 2017 5:30 PM EDT |
Post-ACC Webcast and Genetic Validation of ACL Presentation
Report 2.9 MB
|